Archives
MFGE8 Nanomedicine for Pancreatic Fibrosis
2026-08-22
This study identifies a paracrine antifibrotic mechanism in which umbilical cord mesenchymal stem cell extracellular vesicles deliver MFGE8 to regulate the ANXA1–SMAD2/3 axis in pancreatic stellate cells. It also translates this mechanism into a recombinant MFGE8 nanoparticle platform, linking cell-based therapy, extracellular vesicles, and nanomedicine in chronic pancreatitis models.
Cy3 TSA Fluorescence System Kit for Spatial Biology
2026-08-21
The Cy3 TSA Fluorescence System Kit connects ultrasensitive fluorescence microscopy detection with modern spatial-biology questions. This article explains how tyramide deposition, tissue heterogeneity, and proximity-proteomics insights can guide more defensible IHC, ICC, and ISH assay design.
L-NMMA acetate: NOS Pathway Research Workflows
2026-08-20
L-NMMA acetate provides a practical way to test whether nitric oxide signaling drives osteogenic, inflammatory, or vascular phenotypes. This guide translates dental follicle cell findings into controlled dose-response workflows, pathway readouts, and troubleshooting decisions.
X-Gal and iRhom2: From Clones to Olfactory Biology
2026-08-20
A translational framework for using X-Gal and lacZ reporters to improve construct validation while interpreting iRhom2-dependent olfactory signaling with appropriate mechanistic caution.
Coronavirus Macrodomains and PARP-Mediated Antiviral Defense
2026-08-19
The reference study shows that coronavirus macrodomains counter host ADP-ribosylation by preventing PARP-dependent restriction of viral replication and supporting interferon regulation. Pharmacological inhibition and targeted depletion identify PARP12 and PARP14 as important components of this antiviral response, providing a mechanistic framework for studying coronavirus immune evasion.
Imipramine: A Causal Autophagy Assay Framework
2026-08-19
Imipramine can support integrated autophagy and apoptosis research, but its value depends on distinguishing pathway modulation from endpoint artifacts. This guide adapts lipidomics-based causal reasoning to glioma, leukemia, neuroscience, and immunology assays without overstating cross-domain evidence.
Nutlin-3a and Ferroptosis: A p53 Assay Framework
2026-08-18
Nutlin-3a is a potent MDM2 inhibitor for dissecting p53 pathway activation, cell-cycle control, and apoptosis. This article develops a distinct assay framework that connects MDM2–p53 experiments with the ferroptosis and migration biology described in glioblastoma research.
Pexmetinib (ARRY-614) for Cytokine Assays
2026-08-18
Pexmetinib (ARRY-614) gives researchers a practical way to examine inflammatory cytokine inhibition alongside Tie2-linked signaling. This workflow uses concentration bracketing, whole-blood validation, phospho-protein controls, and dephosphorylation assays to distinguish direct pathway modulation from nonspecific toxicity.
Direct Mouse Genotyping Kit Plus for SCA3 Models
2026-08-17
Discover how the Direct Mouse Genotyping Kit Plus can strengthen genotype-to-phenotype workflows in SCA3/MJD mouse research. This article connects direct tissue lysate PCR with experimental design, model authentication, and interpretation of neuroinflammation and autophagy findings.
Glabridin–Gold(I) Complex Reprograms Tumor Immunity
2026-08-17
The 2025 Advanced Science study develops glabridin–gold(I) complex 6d as an immunomodulatory agent designed to inhibit TrxR and MAPK signaling simultaneously. In liver cancer models, 6d increased dendritic-cell maturation, reduced several immunosuppressive immune populations, lowered tumor-cell PD-L1, and enhanced T-cell granzyme B production, providing a mechanistic rationale for combination immunotherapy studies.
Cryptosporidium AdhE: Imidazole Inhibition and Efficacy
2026-08-16
The reference study establishes the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a chemically tractable target in Cryptosporidium parvum. Screening and follow-up experiments connect lower-micromolar enzyme inhibition by selected antifungal imidazoles with suppression of parasite growth in vitro, while also defining important limits for target validation and therapeutic translation.
RIPostC, Ketone Bodies, and Ferroptosis in Stroke
2026-08-15
This ACS Chemical Neuroscience study identifies ketone body metabolism as a mechanistic link between remote ischemic postconditioning and neuroprotection after ischemic stroke. Rat and neuronal-cell experiments connect the intervention with improved energy status, reduced iron-dependent lipid peroxidation, preservation of GPX4, and suppression of ACSL4, while also defining important limits for translating ketone-body findings into metabolite-specific studies.
Norovirus Co-opts NINJ1 for Selective Secretion
2026-08-14
Song and colleagues show that murine norovirus uses NINJ1-mediated plasma membrane rupture as part of an unconventional, selective route for releasing the viral protein NS1. The study connects caspase-3 cleavage, NINJ1 recruitment to viral replication sites, and NS1–NINJ1 interaction, while demonstrating that this pathway contributes to oral infection in mice.
iPSC Trial Selection for Ultrarare Disease
2026-08-14
The reference study developed a patient-specific iPSC platform to prescreen therapies for an ultrarare ECHS1-related Leigh-like syndrome before further clinical-trial decisions. Its key contribution is a multisystem, control-based workflow that connected cellular drug responses with a subsequent three-year patient treatment experience, while also clarifying the limits of extrapolating results across genetically distinct disorders.
CPI-613 Workflows for Cancer Metabolism Studies
2026-08-13
Build reproducible tumor cell metabolism studies around CPI-613 with dose–time pilots, orthogonal mitochondrial readouts, and combination-testing strategies. The workflow also translates recent cholangiocarcinoma findings into practical assays for PDHA1 activity, α-ketoglutarate accumulation, apoptosis, and macrophage antigen presentation.
611 records 11/41 page Previous Next First page 上5页 1112131415 下5页 Last page